Patient-Derived Drug Discovery

Accelerating breakthrough therapeutics with bespoke drug development solutions using patient cell model, to provide in-depth mitochondrial & cellular insights.

Bespoke Drug Discovery Projects

We specialise in delivering tailored solutions designed to address specific needs in the drug development pipeline. We utilise patient cells providing a highly translatable platform, thoroughly assessing efficacy and toxicity of therapeutic candidates through comprehensive cellular health analysis, with a particular focus on mitochondria and lysosomes. Our services span the preclinical phases from Hit Identification to IND-enabling studies.   We translate this complex patient-derived data into clear, decision-ready insights, with expert data interpretation, giving you the confidence to make those vital go/no-go decisions. 

Accelerating Discovery Through sustained Expertise

At the forefront of drug discovery, our goal is maximum patient benefit. For this, we leverage advanced, high-throughput platform technology to validate compounds, ensuring robust insights that drive your therapeutic discovery process. This is what sets us apart:

Patient-Derived Cell Models

High-Throughput Screening

Expert Analysis

Comprehensive Score

Mitotype Precision Labs was founded on over a decade of pioneering drug discovery, mitochondria and neuroscience research by Professor Heather Mortiboys.

Here’s what our customers say:

Your Partner in Drug Discovery

Get in Touch

We welcome any inquiries regarding our services. Reach out via the form linked below, or email us or contact us via LinkedIn. 

Email Us

info@mitotypeprecisionlabs.com

Stay Informed

Follow us on LinkedIn

Office Location

385a Glossop Road Sheffield S10 2HQ United Kingdom